000 01438 a2200397 4500
005 20250517160849.0
264 0 _c20180402
008 201804s 0 0 eng d
022 _a2047-4881
024 7 _a10.1177/2047487317706586
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchiele, François
245 0 0 _aCoronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention.
_h[electronic resource]
260 _bEuropean journal of preventive cardiology
_c06 2017
300 _a88-100 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBiomarkers
_xblood
650 0 4 _aBlood Coagulation
_xdrug effects
650 0 4 _aBlood Platelets
_xdrug effects
650 0 4 _aCoronary Artery Disease
_xblood
650 0 4 _aDisease Progression
650 0 4 _aDyslipidemias
_xblood
650 0 4 _aFibrinolytic Agents
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHypolipidemic Agents
_xadverse effects
650 0 4 _aLipids
_xblood
650 0 4 _aPatient Selection
650 0 4 _aRecurrence
650 0 4 _aRisk Factors
650 0 4 _aSecondary Prevention
_xmethods
650 0 4 _aTreatment Outcome
700 1 _aEcarnot, Fiona
700 1 _aChopard, Romain
773 0 _tEuropean journal of preventive cardiology
_gvol. 24
_gno. 3_suppl
_gp. 88-100
856 4 0 _uhttps://doi.org/10.1177/2047487317706586
_zAvailable from publisher's website
999 _c27281703
_d27281703